Common variable immunodeficiency disorder: a clinical case

Primary immunodeficiency is a rare congenital pathology associated with failure of immune system, manifested by disturbances of its functions. These defects lead to increased susceptibility of patients to various infectious agents, as well as the development of autoimmune, malignant and other diseases. Primary immunodeficiency is classified as a rare disease, which was previously associated with a poor prognosis with a high risk of mortality in childhood. To date, the emergence of highly effective treatment methods has changed the course and prognosis of these diseases. Clinicians of various specialties increasingly meet with this pathology in everyday practice, including adult age cohorts. In this regard, early diagnosis of primary immunodeficiency in adults becomes relevant, being associated with choosing optimal therapy, prevention of severe internal organ damage, determination of management strategy for the patient, as well as the need to identify inherited disorders and provide information to the patient’s family. Delayed verification of the diagnosis may cause disability of the patient and development of irreversible, often fatal complications. This article presents our own clinical case with a newly diagnosed clinical condition: Common variable immunodeficiency disorder (CVID), the most common form of primary immunodeficiency in adults. The symptoms of common variable immunodeficiency disorder appear in these patients in adulthood, but a high-quality collected history of the disease will allow you to trace symptoms in the patients even since early childhood. There is a common gap for several years between the onset of the disease and clinical diagnosis, since erroneous diagnosis is often made due to non-specific clinical symptoms that resemble other, more frequent diseases. The prognosis of patients with CVID depends on several factors: frequency of infections, structural disorders in the lungs, the occurrence of autoimmune diseases and the success of infection prevention. Thus, a variety of clinical forms of primary immunodeficiency, lack of awareness of doctors about this pathology, complexity of immunological examination in the general medical network lead to the fact that CVID is not diagnosed for long terms, and patients do not receive the necessary pathogenetic therapy. There is a need for drawing attention of doctors of various disciplines to the fact that the recurrent inflammatory processes of various localization, which are difficult to respond to adequate traditional therapy, may be caused by changes in the immune system, including congenital, genetically determined immunodeficiency.

1. Buynova S.N., Shinkareva V.M., Pavlova T.B. Creating a registry of primary immunodeficiencies in children of Irkutsk Region. Sibirskiy meditsinskiy zhurnal = Siberian Medical Journal, 2017, Vol. 133, no. 2, pp. 83-86. (In Russ.)

2. Kozlova I.S. Primary immunodeficiency in Samara Region]. Aspirantskiy vestnik Povolzhiya = Postgraduate Bulletin of the Volga Region, 2015, Vol. 2, no. 5-6, pp. 227-229. (In Russ.)

3. Latysheva E.A. Primary immune deficiency disease in adults. Preferential disturbance of antibody synthesis. Terapiya = Therapy, 2018, Vol. 25, no. 7, pp. 119-124. (In Russ.)

4. Latysheva E.A., Ilyina N.I. Federal clinical recommendations for primary immunodeficiencies in adults: prerequisites, problems, solutions. Rossiyskiy allergologicheskiy zhurnal = Russian Allergology Journal, 2015, no. 1, pp. 38-42. (In Russ.)

5. Al-Herz W., Bousfiha A., Casanova J.L. Primary immunodeficiency disease. An update on the classification from the International Union of Immunological Societies Expert Committee for Primary immunodeficiency. J. Clin. Immunol., 2015, Vol. 35, no. 8, pp. 696-726.

6. Ameratunga R., Brewerton M., Slade C., Jordan A., Gillis D., Steele R., Koopmans W., Woon S.T. Comparison of diagnostic criteria for common variable immunodeficiency disorder. J. Front. Immunol., 2014, Vol. 15, no. 5, pp. 1-9.

7. Bonilla F.A., Barlan I., Chapel H., Costa-Carvalho B.T., Cunningham-Rundles C., de la Morena M.T., Espinosa-Rosales F.J., Hammarström L., Nonoyama S., Quinti I., Routes J.M., Tang M.L., Warnatz K. International Consensus Document (ICON): common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract., 2016, Vol. 4, no. 1, pp. 38-59.

8. Bousfiha A., Jeddane L., Ailal F., Benhsaien I., Mahlaoui N., Casanova J.L., Abel L. Primary immunodeficiency diseases worldwide: more common than generally thought. J. Clin. Immunol., 2013, Vol. 33, no. 1, pp. 1-7.

9. Chapel H. Classification of primary immunodeficiency diseases by International Union of Immunologic Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. J. Clin. Exp. Immunol., 2012, Vol. 168, no. 1, pp. 58-59.

10. Chapel H., Lucas M., Lee M., Bjorkander J., Webster D., Grimbacher B., Fieschi C., Thon V., Abedi M.R., Hammarstrom L. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood, 2008, Vol. 112, no. 2, pр. 277-286.

11. Grimbacher B. The European Society for Immunodeficiencies (ESID) registry 2014. J. Clin. Exp. Immunol., 2014, Vol. 178, no. 1, pp. 18-20.

12. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J. Allergy Clin. Immunol. Pract., 2013, Vol. 1, no. 6, pp. 545-556.

13. Kumar Y., Bhatia A. Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures. J. Expert Rev. Clin. Immunol., 2014, Vol. 10, no. 2, pp. 187-188.

14. Perez E.E., Orange J.S., Bonilla F., Chinen J., Chinn I.K., Dorsey M., El-Gamal Y., Harville T.O., Hossny E., Mazer B., Nelson R., Secord E., Jordan S.C., Stiehm E.R., Vo A.A., Ballow M. Update on the use of immunoglobulin in human disease: a review of evidence. J. Allergy Clin. Immunol., 2017, Vol. 139, no. 3, pp. 1-46.